| Статус: | Completed |
| Фаза: | Phase 3 |
| Начало: | 1 мая 2015 г. |
| Окончание: | 1 ноября 2015 г. |
| Описание: | The purpose of the study is to assess the efficacy and safety of Neuromultivit (solution for injections) in treatment of vertebrogenic radiculopathy L5, S1 in comparison with standard therapy. The patients are randomised into two groups: standard therapy group and standard therapy plus Neuromultivit group. |
| смотреть на ClinicalTrials.gov |